FOLFIRI-CETUXIMAB

Leucovorin, 5-Fluorouracil, Irinotecan, Cetuximab · EGFR-Targeted Colorectal Regimen

Back to Cancer Drug Encyclopedia Find Recruiting Trials with this Drug →

Indications & Uses

First-line treatment of KRAS/NRAS Wild-Type Metastatic Colorectal Cancer.

Contraindications

Tumors with documented KRAS or NRAS mutations (lack of efficacy).

Side Effects & Warnings

Acneiform skin rash, hypomagnesemia, infusion reactions, paronychia, diarrhea.

Drug & Dietary Interactions

Extensive interactions; consult specific multi-agent administration and hydration protocols.

For educational and informational purposes only. Do not alter medication doses or regimens without consulting your licensed oncology physician or care team.

Patient & Caregiver Support

Ask About This Medication

Connect with an ONC-ORG counselor regarding drug access, copay relief, patient assistance programs, or related clinical trials.